Guggenheim analyst Seamus Fernandez raised the firm’s price target on Sanofi to EUR 118 from EUR 117 and keeps a Buy rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNY:
- DarioHealth’s Dario shows reduction of diabetes patient hospital readmissions
- Sanofi says amlitelimab Phase 2b data show ‘potential best-in-class’ AD profile
- Bristol Myers (NYSE:BMY) Boosts Oncology Portfolio with $5.8B Mirati Deal
- Negative Amgen AdCom a positive for Mirati, says Jefferies
- Mirati Therapeutics price target raised to $72 from $31 at BMO Capital